Clinical Trial Update: A Phase II Trial of RAB001 (LLP2A-Alendronate) for Steroid-Induced Early-Stage Osteonecrosis of the Femoral Head [Phase 2]

View source ↗

Summary

This is a Phase II trial update for RAB001 (LLP2A-Alendronate) evaluating steroid-induced early-stage osteonecrosis of the femoral head; the study is currently …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteonecrosis
• Osteonecrosis of the Femoral Head

Drugs mentioned

• RAB001 (LLP2A-Alendronate)

Snippet

Sponsor: ZhongShan LaiBo RuiChen BioMedicine Co.,Ltd. | Conditions: Osteonecrosis, Osteonecrosis of the Femoral Head | Phase 2 | Status: ACTIVE_NOT_RECRUITING